Zobrazeno 1 - 10
of 49
pro vyhledávání: '"CD4+ T helper cell"'
Autor:
Mia Mosavie, Jennifer Rynne, Matthew Fish, Peter Smith, Aislinn Jennings, Shivani Singh, Jonathan Millar, Heli Harvala, Ana Mora, Fotini Kaloyirou, Alexandra Griffiths, Valerie Hopkins, Charlotte Washington, Lise J. Estcourt, David Roberts, Manu Shankar-Hari
Publikováno v:
Vaccines, Vol 12, Iss 9, p 1040 (2024)
Molecular changes in lymphocytes following SARS-CoV-2 vaccination are incompletely understood. We hypothesized that studying the molecular (transcriptomic, epigenetic, and T cell receptor (TCR) repertoire) changes in CD4+ T cells following SARS-CoV-2
Externí odkaz:
https://doaj.org/article/b9aa3ec877b240a59a25b8880a77c908
Autor:
Julia Strandmark, Alansana Darboe, Joann Diray-Arce, Rym Ben-Othman, Sofia M. Vignolo, Shun Rao, Kinga K. Smolen, Geert Leroux-Roels, Olubukola T. Idoko, Guzmán Sanchez-Schmitz, Al Ozonoff, Ofer Levy, Tobias R. Kollmann, Arnaud Marchant, Beate Kampmann
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
A single birth-dose of Hepatitis B vaccine (HepB) can protect newborns from acquiring Hepatitis B infection through vertical transmission, though several follow-up doses are required to induce long-lived protection. In addition to stimulating antibod
Externí odkaz:
https://doaj.org/article/18f04a70e1674e919905aded5c30ad0c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Robin E. Walsh, Megan Lannan, Yi Wen, Xiaoli Wang, Christopher A. Moreland, Jill Willency, Michael D. Knierman, Laura Spindler, Ling Liu, Wei Zeng, Guilherme V. Rocha, Victor Obungu, Jirong Lu, Arunan Kaliyaperumal, Andrea Ferrante, Robert Siegel, Laurent P. Malherbe
Publikováno v:
mAbs, Vol 12, Iss 1 (2020)
Biologics have the potential to induce an immune response when used therapeutically. A number of in vitro assays are currently used preclinically to predict the risk of immunogenicity, but the validation of these preclinical tools suffers from the re
Externí odkaz:
https://doaj.org/article/28841672b87f4adda992076575ebfe5a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alasdair Russell
Publikováno v:
Cell
Summary T helper type 2 (Th2) cells are important regulators of mammalian adaptive immunity and have relevance for infection, autoimmunity, and tumor immunology. Using a newly developed, genome-wide retroviral CRISPR knockout (KO) library, combined w
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Michael D. Knierman, Ling Liu, Megan B. Lannan, Christopher A. Moreland, Yi Wen, Laura J. Spindler, Jill A. Willency, Victor H. Obungu, Andrea Ferrante, Robert W. Siegel, Robin E. Walsh, Arunan Kaliyaperumal, Guilherme Rocha, Jirong Lu, Laurent Malherbe, Xiaoli Wang, Wei Zeng
Publikováno v:
mAbs
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Biologics have the potential to induce an immune response when used therapeutically. A number of in vitro assays are currently used preclinically to predict the risk of immunogenicity, but the validation of these preclinical tools suffers from the re
Autor:
Giuseppe Ercolano, Camilla Jandus, Sara Trabanelli, Pedro Romero, Tania Wyss, Bérengère Salomé
Publikováno v:
Journal of Leukocyte Biology
Journal of Leukocyte Biology (2020)
Journal of Leukocyte Biology (2020)
Innate lymphoid cells (ILCs) are the latest identified innate immune cell family. Given their similarity in transcription factor expression and cytokine secretion profiles, ILCs have been considered as the innate phenocopy of CD4 Th cells. Here, we e
Autor:
Xi Chen, Johan Henriksson, Kerstin B. Meyer, Ricardo J. Miragaia, Sarah A. Teichmann, Riitta Lahesmaa, Tomás Gomes, Kosuke Yusa, Graham Duddy, Jhuma Pramanik, Ubaid Ullah
Publikováno v:
bioRxiv
Cell
Cell
T helper type 2 (Th2) cells are important regulators of mammalian adaptive immunity and have relevance for infection, auto-immunity and tumour immunology. Using a newly developed, genome-wide retroviral CRISPR knock-out (KO) library, combined with RN